TriMed
Private Company
Total funding raised: $17.5M
Overview
TriMed is a specialized orthopedic device company with a 30+ year history of developing fragment-specific fixation systems for complex periarticular fractures, primarily in the wrist, ankle, and other extremities. The company has carved out a niche by addressing limitations of traditional fixation methods, leveraging innovative designs like the Volar Bearing Plate and Sidewinder Plate. While smaller than many competitors, TriMed emphasizes superior customer service, surgeon education through seminars, and a strong clinical evidence base to maintain its position as a key player in the orthopedic trauma segment.
Technology Platform
Fragment-Specific Fixation (FSF) - A modular system of low-profile orthopedic implants designed for stable, multi-planar fixation of complex periarticular fractures, moving beyond traditional anatomic plates.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
TriMed competes in the orthopedic trauma device market, which is dominated by large public companies like Stryker, DePuy Synthes (Johnson & Johnson), Zimmer Biomet, and Smith & Nephew. Its competitive advantage is not scale, but deep specialization, innovative fragment-specific designs, and superior customer service for complex periarticular fractures, a niche where larger players may offer less tailored solutions.